The study of liophilization parameters in the liposomal irinotecan development
DOI:
https://doi.org/10.24959/nphj.17.2182Keywords:
liposomes, chemical gradient, high pressure extrusion, cryoprotector, freeze dryingAbstract
The creation of the liposomal irinotecan is one of the main ways to reduce toxicity and increase the effectiveness of chemotherapy. Lyophilization makes it possible to obtain a product with a guaranteed stability of the size and encapsulation efficiency.
Aim. To optimize the content of the cryoprotector in the liposomal irinotecan, and develop lyophilization parameters to produce liposomes with the maximum encapsulation of irinotecan in them, alongside while maintaining the nanosize.
Materials and methods. Egg phosphatidylcholine from Lipoid (Germany) was used for preparation of liposomes. Lyophilization was carried out in a Quarco device (PR China). The encapsulation degree was determined on a Shimadzu LC-20 instrument (Japan) by HPLC method developed earlier.
Results and discussion. The optimal content of the cryoprotector – trehalose dihydrate has been studied. It has been found that the optimal content of trehalose dihydrate is 8 % (w/w). The modes of the product lyophilization have been studied. The secondary drying temperature in the range of 10-20 °C has been determined. At the secondary drying temperature of 10 °C the residual moisture content was 5-8 %, which was beyond the target range. At 20 °C the water content in the lyophilizate was 0.5-0.8 %, the loss of encapsulation was up to 20 %. The mode of drying at 15 °C was optimal, while the residual water content in the lyophilizate was 1.5-2.8 %, the loss of encapsulation was 13 %, the size of the liposomes after lyophilization and rehydration did not change significantly compared to the initial one.
Conclusions. As a result of the studies, liposomes with irinotecan have been obtained. The content of trehalose dihydrate as a cryoprotector in the range of 4-10 % has been studied. It has been shown that the optimum content of trehalose dihydrate is 8 % (w/w); moreover, the encapsulation decrease in lyophilization is 13 %. The modes of the liposomal irinotecan lyophilization have been studied at the final drying temperature of 10, 15 and 20 °C. It has been found that the optimum final drying temperature is 15 °C.
References
Flosdorf, E. W. (1949). Freeze–drying. New York: Reinhold Publishing Corp., 217.
Cameron, P. (1997) Good pharmaceutical freeze–drying practice. Buffalo Grove: Interpharm Press, 47.
Franks, F. (2007). Freeze–Drying of Pharmaceutical and Biopharmaceuticals. London: RSC Publishing, 206.
Chen, G., Wang, W. (2007). Role of Freeze Drying in Nanotechnology. Drying Technology, 25 (1), 29–35. doi: 10.1080/07373930601161179
Shvets, V. I., Krasnopolskyi, Yu. M. (2008). Liposomes in Pharmacy. Products of nanobiotechnology. The Provizor, 3, 18–24.
Baryshnikov, A. Yu. (2012). Nanostructured liposomal systems as a tool for delivery of antitumor drugs. Actual questions of oncology. Bulletin of the Russian Academy of Medical Sciences, 3, 23–31.
Bajetta, E., Beretta, E., Di Bartolomeo, M., Cortinovis, D., Ferrario, E., Dognini, G., Buzzoni, R. (2004). Efficacy of Treatment with Irinotecan and Oxaliplatin Combination in FU–Resistant Metastatic Colorectal Cancer Patients. Oncology, 66 (2), 132–137. doi: 10.1159/000077439
Wang, L., Hu, X., Shen, B., Xie, Y., Shen, C., Lu, Y., Wu, W. (2015). Enhanced stability of liposomes against solidification stress during freeze–drying and spray–drying by coating with calcium alginate. Journal of Drug Delivery Science and Technology, 30, 163–170. doi: 10.1016/j.jddst.2015.10.012
Sylvester, B., Porfire, A., Van Bockstal, P.–J., Porav, S., Achim, M., Beer, T. D., Tomuţă, I. (2017). Formulation Optimization of Freeze–Dried Long–Circulating Liposomes and In–Line Monitoring of the Freeze–Drying Process Using an NIR Spectroscopy Tool. Journal of Pharmaceutical Sciences. doi: 10.1016/j.xphs.2017.05.024
Stark, B., Pabst, G., Prassl, R. (2010). Long–term stability of sterically stabilized liposomes by freezing and freeze–drying: Effects of cryoprotectants on structure. European Journal of Pharmaceutical Sciences, 41 (3–4), 546–555. doi: 10.1016/j.ejps.2010.08.010
11. IAPWS Revised Release on the Pressure along the Melting and Sublimation Curves of Ordinary Water Substance. (2011). Available at: http://www.iapws.org/relguide/MeltSub2011.pdf
Stadnichenko, A. V., Krasnopolskyi, Yu. M., Shvets, V. I. (2015). Development and validation of the method for encapsulation degree determination of irinotecan hydrochloride in liposomes. Biopharmaceutical Journal, 7 (1), 53–55.
Stadnichenko, A. V. (2016) Investigation of the irinotecan stability in various methods for liposomes loading. ScienceRise:Pharmaceutical Science, 2, 30–36.
Stadnichenko, A. V., Krasnopolskyi, Yu. M., Shvets, V. I. (2014). The technology of liposomal forms of irinotecan (review). Biopharmaceutical Journal, 6 (6), 3–9.
Bosch, S., de Beaurepaire, L., Allard, M., Mosser, M., Heichette, C., Chrétien, D., Bach, J.–M. (2016). Trehalose prevents aggregation of exosomes and cryodamage. Scientific Reports, 6 (1). doi: 10.1038/srep36162
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
